share_log

HC Wainwright & Co. Maintains Buy on MEI Pharma, Lowers Price Target to $2

Benzinga Real-time News ·  Feb 13, 2023 19:18

HC Wainwright & Co. analyst Andrew Fein maintains MEI Pharma (NASDAQ:MEIP) with a Buy and lowers the price target from $5 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment